Ocugen Inc seeks to sell 100 million doses of India’s statebacked COVID19 vaccine COVAXIN in the United States this year, the U.S. firm’s chief executive Shankar Musunuri told Reuters on Monday.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.